Patents Assigned to Xeltis AG
  • Patent number: 11872134
    Abstract: Bioabsorbable medical devices such as vascular closures, mitral chorea replacements, and mitral leaflet extensions are provided.
    Type: Grant
    Filed: March 1, 2022
    Date of Patent: January 16, 2024
    Assignee: Xeltis AG
    Inventors: Youssef Biadillah, Martijn Antonius Johannes Cox
  • Patent number: 11767613
    Abstract: A method of making a medical implant is provided by electrospinning a polymer solution to form a preform around a mandrel. The formed preform distinguishes an inner surface and an outer surface. The formed preform is removed from the mandrel and flipped inside-out resulting in the inner surface of the formed preform becoming the outer surface of the inside-out flipped preform, and the outer surface of the formed preform becoming the inner surface of the inside-out flipped preform. At least part of the inside-out flipped preform forms the medical implant such as e.g. an artificial heart valve, an artificial leaflet, an artificial graft, or an artificial vessel. The products made according to the method of this invention greatly improve the performance and durability of the medical implant.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: September 26, 2023
    Assignee: Xeltis AG
    Inventors: Jurgen Sander Miedema, Martijn Antonius Johannes Cox, Christophe Pierre Edouard Naz
  • Patent number: 11744591
    Abstract: A medical device for an anastomosis is provided. The medical device distinguishes an inner tubular layer, an outer tubular layer, and a support element defining a longitudinal axis. It further distinguishes two or more independent C-rings distributed and positioned at an acute orientation angle relative to the longitudinal axis of the support element at one end of the support element. The support element and the two or more C-rings are embedded in between the inner and the outer tubular layers. The types of applications one could envision are e.g. a proximal anastomosis, distal anastomosis, or side-to-side anastomoses, in a customized pre-fabricated graft. Embodiments of the invention could also be incorporated into an anastomotic connector device design. Embodiments of the invention could further be envisioned as vascular grafts applications such as Coronary Artery Bypass Graft (CABG), dialysis access grafts and peripheral vascular applications.
    Type: Grant
    Filed: February 24, 2021
    Date of Patent: September 5, 2023
    Assignee: Xeltis AG
    Inventors: Yonatan Gray, Mohammed El-Kurdi
  • Patent number: 11452624
    Abstract: The disclosure lies in the field of regenerative medicine and relates to an implant having a matrix material, and a method for manufacturing an implant having matrix material. The disclosure further relates to a crimped implant.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: September 27, 2022
    Assignee: Xeltis AG
    Inventors: Tom Lavrijsen, Anandkumar Nandakumar, Martijn Antonius Johannes Cox, Franciscus Petrus Thomas Baaijens, Carolina Victoria Catharina Bouten, Anton Bosman, Tristan Mes, Patricia Yvonne Wilhelmina Dankers
  • Patent number: 10953139
    Abstract: A biodegradable cardiovascular implant is provided for growing cardiovascular tissue in a patient. The implant distinguishes an electro-spun network with supramolecular compounds having hard-blocks covalently bonded with soft-blocks resulting in much enhanced durability and fatigue resistance, while maintaining the effectiveness as a cardiovascular implant.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: March 23, 2021
    Assignee: Xeltis AG
    Inventors: Aurelie Serrero, Martijn Antonius Johannes Cox
  • Patent number: 10905796
    Abstract: A supramolecular polymer blend includes a thermoplastic elastomer functionalized with at least one bis-urea moiety and a functional component which is functionalized with at least one bis-urea moiety which is present in an amount of 0.5-40 wt % based on the total mass of the polymer blend. The functional component is selected from polyalkylene glycol, betaine, polysaccharide, zwitterion, polyol or taurine and derivatives thereof. Implants including the polymer blend and a process to manufacture the implants are also provided.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: February 2, 2021
    Assignees: Xeltis AG, Technische Universiteit Eindhoven
    Inventors: Patricia Dankers, Björne Mollet, Samaneh Kheyrrooz, Bastiaan Ippel, Henk Keizer, Geert Van Almen, Frank Baaijens
  • Patent number: 10876222
    Abstract: Endoluminal and other as implantable prostheses are fabricated in electrospinning apparatus including a target and an applicator. A solution comprising a polymer and a solvent is directed to the target with a first electrical potential between the target and the applicator to produce a first set of fibers. The same or another solution is continued to be delivered through the applicator onto the target while applying a second electrical potential to produce a second set of fibers having a second solvent fraction, and the same or different solution may be delivered while applying a third potential difference to produce a laminated structure having at least three layers. By properly controlling the electrical potentials and solvent fractions, an adhesive layer can be formed to serve a glue or adhesive between the inner and outer layers, and a stent or other scaffold may be positioned between the inner and outer layers to form a covered stent or graft.
    Type: Grant
    Filed: October 3, 2016
    Date of Patent: December 29, 2020
    Assignee: Xeltis AG
    Inventors: Christophe Pierre Edouard Naz, Anandkumar Nandakumar, Oleg Svanidze, Martijn Antonius Johannes Cox, Fabio Zomer Volpato
  • Patent number: 10695162
    Abstract: A system for applying a fiber matrix on a tubular member is provided. A mandrel, configured for atraumatic placement within the tubular member, is included. Methods for atraumatic placement of a mandrel into a tubular member are also provided.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: June 30, 2020
    Assignee: Xeltis AG
    Inventors: Lorenzo Soletti, Mohammed S. El-Kurdi, Jon McGrath, J. Christopher Flaherty, Liem Vu, Jerry Brightbill, Stephen Evans, Joseph Ting, David Rezac, Timothy Robinson
  • Patent number: 10687966
    Abstract: The disclosure lies in the field of regenerative medicine and relates to an implant having a matrix material, and a method for manufacturing an implant having matrix material. The disclosure further relates to a crimped implant.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: June 23, 2020
    Assignees: Xeltis AG, Technische Universiteit Eindhoven
    Inventors: Tom Lavrijsen, Anandkumar Nandakumar, Martijn Antonius Johannes Cox, Franciscus Petrus Thomas Baaijens, Carolina Victoria Catharina Bouten, Anton Bosman, Tristan Mes, Patricia Yvonne Wilhelmina Dankers